257 related articles for article (PubMed ID: 24057815)
21. The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine.
Montezinho LP; Miller S; Plath N; Jensen NH; Karlsson JJ; Witten L; Mørk A
Psychopharmacology (Berl); 2010 Oct; 212(2):131-43. PubMed ID: 20676614
[TBL] [Abstract][Full Text] [Related]
22. Noradrenergic mechanisms in cocaine-induced reinstatement of drug seeking in squirrel monkeys.
Platt DM; Rowlett JK; Spealman RD
J Pharmacol Exp Ther; 2007 Aug; 322(2):894-902. PubMed ID: 17505018
[TBL] [Abstract][Full Text] [Related]
23. Behavioral disinhibition requires dopamine receptor activation.
van Gaalen MM; Brueggeman RJ; Bronius PF; Schoffelmeer AN; Vanderschuren LJ
Psychopharmacology (Berl); 2006 Jul; 187(1):73-85. PubMed ID: 16767417
[TBL] [Abstract][Full Text] [Related]
24. Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects.
Fletcher PJ; Sinyard J; Salsali M; Baker GB
Psychopharmacology (Berl); 2004 Jul; 174(3):406-13. PubMed ID: 14740149
[TBL] [Abstract][Full Text] [Related]
25. Modulation of cocaine-induced motor activity in the rat by opioid receptor agonists.
Waddell AB; Holtzman SG
Behav Pharmacol; 1998 Sep; 9(5-6):397-407. PubMed ID: 9832925
[TBL] [Abstract][Full Text] [Related]
26. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
Weikop P; Kehr J; Scheel-Krüger J
J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
[TBL] [Abstract][Full Text] [Related]
27. Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction.
Sills TL; Greenshaw AJ; Baker GB; Fletcher PJ
Psychopharmacology (Berl); 1999 Feb; 141(4):421-7. PubMed ID: 10090650
[TBL] [Abstract][Full Text] [Related]
28. The effects of cocaine on cerebral metabolic function in periweanling rats: the roles of serotonergic and dopaminergic uptake blockade.
Frick GS; Dow-Edwards DL
Brain Res Dev Brain Res; 1995 Sep; 88(2):158-70. PubMed ID: 8665662
[TBL] [Abstract][Full Text] [Related]
29. Methylphenidate and atomoxetine inhibit social play behavior through prefrontal and subcortical limbic mechanisms in rats.
Achterberg EJ; van Kerkhof LW; Damsteegt R; Trezza V; Vanderschuren LJ
J Neurosci; 2015 Jan; 35(1):161-9. PubMed ID: 25568111
[TBL] [Abstract][Full Text] [Related]
30. Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat.
Herges S; Taylor DA
Pharmacol Biochem Behav; 1998 Mar; 59(3):595-611. PubMed ID: 9512061
[TBL] [Abstract][Full Text] [Related]
31. The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists.
Fletcher PJ; Sinyard J; Higgins GA
Psychopharmacology (Berl); 2006 Sep; 187(4):515-25. PubMed ID: 16832658
[TBL] [Abstract][Full Text] [Related]
32. Effects of a 5-HT7 receptor antagonist DR4004 on the exploratory behavior in a novel environment and on brain monoamine dynamics in mice.
Takeda H; Tsuji M; Ikoshi H; Yamada T; Masuya J; Iimori M; Matsumiya T
Eur J Pharmacol; 2005 Jul; 518(1):30-9. PubMed ID: 16002064
[TBL] [Abstract][Full Text] [Related]
33. Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.
Harrison AA; Liem YT; Markou A
Neuropsychopharmacology; 2001 Jul; 25(1):55-71. PubMed ID: 11377919
[TBL] [Abstract][Full Text] [Related]
34. Continuous infusion of selective dopamine uptake inhibitors or cocaine produces time-dependent changes in rat locomotor activity.
Izenwasser S; French D; Carroll FI; Kunko PM
Behav Brain Res; 1999 Mar; 99(2):201-8. PubMed ID: 10512586
[TBL] [Abstract][Full Text] [Related]
35. Antidepressants differentially affect striatal amphetamine-stimulated dopamine and serotonin release in rats with high and low novelty-oriented behaviour.
O'Leary A; Kõiv K; Raudkivi K; Harro J
Pharmacol Res; 2016 Nov; 113(Pt B):739-746. PubMed ID: 26920253
[TBL] [Abstract][Full Text] [Related]
36. Alterations in behavior and opioid gene expression induced by the novel tropane analog WF-31.
Daunais JB; Hart SL; Hedgecock-Rowe A; Matasi JJ; Thornley C; Davies HM; Porrino LJ
Brain Res Mol Brain Res; 1997 Oct; 50(1-2):293-304. PubMed ID: 9406946
[TBL] [Abstract][Full Text] [Related]
37. Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats.
Markou A; Harrison AA; Chevrette J; Hoyer D
Psychopharmacology (Berl); 2005 Mar; 178(2-3):133-42. PubMed ID: 15452682
[TBL] [Abstract][Full Text] [Related]
38. Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats.
Bari A; Eagle DM; Mar AC; Robinson ES; Robbins TW
Psychopharmacology (Berl); 2009 Aug; 205(2):273-83. PubMed ID: 19404616
[TBL] [Abstract][Full Text] [Related]
39. Dopamine-sensitive signaling mediators modulate psychostimulant-induced ultrasonic vocalization behavior in rats.
Williams SN; Undieh AS
Behav Brain Res; 2016 Jan; 296():1-6. PubMed ID: 26275925
[TBL] [Abstract][Full Text] [Related]
40. Bidirectional cannabinoid modulation of social behavior in adolescent rats.
Trezza V; Vanderschuren LJ
Psychopharmacology (Berl); 2008 Apr; 197(2):217-27. PubMed ID: 18058088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
